跳至主要内容
临床试验/NCT02967055
NCT02967055已完成不适用

The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant

University of Colorado, Denver1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2017年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
9
试验地点
1
主要终点
Serum Etonogestrel (ENG) Level

研究概览

简要总结

This exploratory study will fill a knowledge gap regarding the pharmacokinetic effects of isotretinoin on the etonogestrel (ENG) contraceptive implant.

详细描述

The Investigators will enroll only women with an etonogestrel contraceptive implant in place who are initiating isotretinoin therapy through their dermatologist. The Investigators will monitor the subjects serum etonogestrel concentration during isotretinoin therapy but no medications will be provided through this study. No medical devices will be inserted as part of this study either.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Have a secondary form of non-hormonal contraception or abstain during isotretinoin therapy and four weeks afterwards
  • Have at least two negative pregnancy tests at least 19 days apart prior to initiating isotretinoin therapy
  • Have normal baseline laboratory evaluation including liver function tests, basic metabolic panel, and complete blood count
  • Willing to abstain from taking any Vitamin A supplement during the study period
  • Have a Body Mass Index (BMI) >= 18.5

排除标准

  • Currently breastfeeding
  • Known contraindications to isotretinoin
  • Currently taking any known cytochrome P-450 3A4 enzyme inducers or inhibitors

结局指标

主要结局

Serum Etonogestrel (ENG) Level

时间窗: 9 weeks

ENG levels will be measured 9 weeks after of initiation of isotretinoin therapy.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验